A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly
- 7 September 2023
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 218, 105715
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82072280, 82272315)
- Natural Science Foundation of Beijing Municipality (7212063, 7222108)
- National Key Research and Development Program of China (2022YFA1303600)
This publication has 36 references indexed in Scilit:
- The novel compound Z060228 inhibits assembly of the HBV capsidLife Sciences, 2015
- Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle AssemblyAntimicrobial Agents and Chemotherapy, 2013
- In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutationsAntiviral Therapy, 2012
- Hepatitis B Precore Protein: Pathogenic Potential and Therapeutic PromiseYonsei Medical Journal, 2012
- Secretion of Genome-Free Hepatitis B Virus – Single Strand Blocking Model for Virion Morphogenesis of Para-retrovirusPLOS Pathogens, 2011
- Characterization of Hepatitis B Virus Capsids by Resistive-Pulse SensingJournal of the American Chemical Society, 2011
- Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B VirusJournal of Virology, 2010
- A Mutant Hepatitis B Virus Core Protein Mimics Inhibitors of Icosahedral Capsid Self-AssemblyBiochemistry, 2009
- Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapyJournal of Gastroenterology, 2006
- Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopyCell, 1994